Clive Bates

Clive is a versatile policy maker and strategist. He has diverse domestic and international experience from the private sector (~7 years), third sector (~11 years) and government (~8 years). Can see risks and opportunities from many different angles. His specialisms are in energy, environment and public health. Clive's blog: http://www.clivebates.com

What is vaping?

Clive Bates | 29 December 2016

Sometimes we find ourselves talking at cross-purposes about vaping. Why? Consider three perspectives.

First, a health professional asks: “how should vaping be understood and used (or not) to reduce the adverse health effects of smoking?”

Read more ...

WHO position on ENDS - a critique of the use of science and communication of risk

Clive Bates | 14 September 2014

A new paper is published today: WHO position on ENDS: a critique of the use of science and communication of risk (PDF) written and researched by Clive Bates at Counterfactual
 
We have grown accustomed to WHO and the FCTC Secretariat taking a negative approach to tobacco harm reduction - seeing only risks and threats, and little of the real world potential, while covertly planning an offensive against e-cigarettes through the Framework Convention on Tobacco Control. Yet the evidence is steadily moving against that position, leaving WHO looking more extreme, unscientific and ideologically motivated as the data accumulates.
 

Read more ...

Making sense of the proposed new e-cigarette regulations

Clive Bates | 20 December 2013

As the final negotiation over e-cigarettes in the tobacco products directive drew to a close. a nameless ‘senior diplomat involved in the negotiations’ was quoted in The Guardian. They were talking about e-cigarettes:It’s inhaled. It’s direct inhalation of nicotine into the lungs. That creates an addiction very fast… I t encourages a switch to real cigarettes.”

E-cigs and regulation – what do investment analysts think?

Clive Bates | 17 November 2013

The investment analysts are always interesting on tobacco and e-cigs, and in a usefully dispassionate ‘follow-the-money’ kind of way.

Here’s a small collection of quotes I’ve seen in recent analyst reports mainly as they relate to regulation of e-cigarettes. I don’t see all reports of course so this is necessarily selective.

Read more ...